These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Growth inhibition of tanshinones on SPC-A-1 cell line and their structure-activity relationship].
    Author: Shi H, Zhang Q, Li H, Chu T, Jin H, Mao S.
    Journal: Zhongguo Fei Ai Za Zhi; 2011 Jan; 14(1):7-12. PubMed ID: 21219824.
    Abstract:
    BACKGROUND AND OBJECTIVE: Numerous studies have shown that Tanshinones have anti-tumor effects in vitro, but few studies were focusing on the anti-tumor activity of Tanshinones against one special cancer cell line. The aim of this study is to investigate the growth inhibition effect of four Tanshinones on SPC-A-1 cell line and the relationship between their structures and cytotoxicity. METHODS: The modified MTT assay was adopted to measure the inhibition effect of Tanshinones on SPC-A-1 cells at different concentrations at 24 h, 48 h and 72 h, and the changes of cell morphology were observed by inverted phase contrast microscope. RESULTS: Tanshinones could inhibit the proliferation of SPC-A-1 cells effectively, and their cytotoxicities on SPC-A-1 cells are all in concentration-dependent and time-dependent manners. The IC50 of dihydro-Tanshinone I, Tanshinone I, Tanshinone IIA and Cryptotanshinone at 24 h were 2.77 μg/mL, 6.01 μg/mL, over 10 μg/mL and over 10 μg/mL, at 48 h were 1.80 μg/mL, 4.04 μg/mL, 8.12 μg/mL, 8.71 μg/mL, at 72 h were 1.36 μg/mL, 1.69 μg/mL, 3.81 μg/mL, 7.35 μg/mL, respectively. CONCLUSIONS: All of the four Tanshinones have proliferation inhibitory effects on SPC-A-1 cell line, among which the Dihydrotanshinone I is the most active one, followed by Tanshinone I, Tanshinone IIA and Cryptotanshinone subsequently. The results showed that the structure of aromatic ring A could enhance the cytotoxicity and the structure of furan ring C would influence the cytotoxicity, but the mechanism is still remained to be further investigated. 背景与目的: 大量研究表明丹参酮类化合物具有体外抗肿瘤作用,但很少有人综合研究丹参酮类化合物对同一种肿瘤细胞的作用情况。本文旨在比较4种丹参酮类化合物对SPC-A-1细胞的增殖抑制作用,并探讨其结构与细胞毒性之间的关联性。 方法: 采用改良MT法测定不同浓度的丹参酮类化合物与细胞共培养预定时间(24 h、48 h和72 h)后对SPC-A-1细胞的增殖抑制作用;倒置显微镜下观察不同药物处理对于SPC-A-1细胞的形态学影响。 结果: 丹参酮类化合物均能有效抑制SPC-A-1细胞增殖,其抑制作用呈明显的时间和剂量依赖性。二氢丹参酮Ⅰ、丹参酮Ⅰ、丹参酮ⅡA、隐丹参酮作用24 h的IC50值分别为2.77 μg/mL、6.01 μg/mL、 > 10 μg/mL和 > 10 μg/mL;作用48 h的IC50值分别为1.80 μg/mL、4.04 μg/mL、8.12 μg/mL、8.71 μg/mL;作用72 h的IC50值分别为1.36 μg/mL、1.69 μg/mL、3.81 μg/mL、7.35 μg/mL。 结论: 4种丹参酮类化合物均对SPC-A-1细胞具有明显的增殖抑制作用,作用强度大小依次为二氢丹参酮Ⅰ、丹参酮Ⅰ、丹参酮ⅡA、隐丹参酮,提示A环为芳环时可增强细胞毒性,C环的呋喃环结构可能影响其细胞毒性,其具体作用机理尚有待探讨。
    [Abstract] [Full Text] [Related] [New Search]